Dolasetron Injection and Pacritinib: Interaction Details

Brand names
Dolasetron Injection
Anzemet
Pacritinib
Vonjo
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Dolasetron Injection and Pacritinib interaction:

Share

Share this interaction

Dolasetron Injection

Brand name
  • Anzemet

We don't have a drug information page for Dolasetron Injection yet. Have a question about Dolasetron Injection? Ask a pharmacist, free →

What Happens When You Take Dolasetron Injection With Pacritinib

What can happen when they are taken together (rated Major)

An increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Pacritinib should not be given together with any drug known to prolong the . Drugs that lengthen the can add to the QTc-prolonging effect of pacritinib and raise the risk of cardiac .

Pacritinib should also be avoided in patients whose baseline QTc exceeds 480 msec. Pacritinib should be held if the QT interval extends beyond 500 msec or rises more than 60 msec above baseline.

Once QTc prolongation returns to 480 msec or less, or to baseline, within 1 week, pacritinib can be resumed at the same dose. If resolution takes longer than 1 week, pacritinib should be resumed at a reduced dose. When cannot be avoided, should be corrected before and throughout pacritinib treatment, and QTc prolongation should be handled by interrupting pacritinib and managing electrolytes.1

The Dolasetron Injection and Pacritinib Interaction, Explained

Dolasetron (Anzemet) is an injection used to prevent nausea and vomiting. Pacritinib (Vonjo) is a medicine for myelofibrosis. Both can affect your heart's electrical rhythm, called the . Taking them together may add up that effect and raise the chance of an irregular heartbeat. This is a theoretical concern based on how the drugs work, not on many reported cases, but it is taken seriously.

Please don't stop or change anything on your own. Tell your pharmacist or doctor about every medicine you take. Your care team can check your heart rhythm and potassium levels and may choose a different nausea medicine.

Mechanism: (dolasetron/hydrodolasetron and pacritinib both prolong ). This is not a interaction. Evidence is theoretical; severity is major; onset is unspecified.

  • Avoid with QT-prolonging drugs when possible.
  • Avoid pacritinib if baseline QTc is above 480 msec.
  • If QTc exceeds 500 msec or rises more than 60 msec from baseline, hold pacritinib. If it resolves to 480 msec or less (or baseline) within 1 week, restart at the same dose. If resolution takes longer than 1 week, restart at a reduced dose.
  • If use is unavoidable, correct before and during therapy, and manage QTc with interruption and electrolyte management.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Dolasetron Injection and Pacritinib Interact

The likely mechanism


In short: Dolasetron injection and pacritinib both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Dolasetron Injection and Pacritinib Interaction

Your care team has several ways to manage this. The preferred approach is to avoid the combination, for example by choosing a different anti-nausea medicine.

  • If both are needed, your team may check your heart rhythm () and correct low potassium before and during treatment.
  • If your QTc rises too much, pacritinib may be paused, then restarted at the same or a lower dose depending on how quickly it recovers.
  • Keep taking your medicines as prescribed unless your team tells you otherwise.
  • Tell your pharmacist or prescriber about any dizziness, fainting, or a racing or fluttering heartbeat, and about all other medicines you use.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Dolasetron Injection or Pacritinib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Dolasetron Injection and Pacritinib: Common Questions

How serious is the Dolasetron Injection and Pacritinib interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Dolasetron Injection and Pacritinib interaction managed?

Your care team has several ways to manage this. The preferred approach is to avoid the combination, for example by choosing a different anti-nausea medicine. If both are needed, your team may check your heart rhythm () and correct low potassium before and during treatment. If your QTc rises too much, pacritinib may be paused, then restarted at the same or a lower dose depending on how quickly i… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Dolasetron Injection and Pacritinib Interaction

Ask in your own words about taking Dolasetron Injection and Pacritinib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: VONJO(R) oral capsules, pacritinib oral capsules. CTI BioPharma Corp (per FDA), Seattle, WA, 2024. DailyMed
Was this write-up helpful?

Other Serious Interactions of Dolasetron Injection and Pacritinib

Also serious with Dolasetron Injection

Also serious with Pacritinib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Pacritinib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.